Evive Biotech: Develop Novel Therapies for Patients Worldwide

You are now leaving the Evive Biotech website. Evive offers links to other third party websites that may be of interest to our website visitors. When you click on these links you will leave the Evive’s website and will be redirected to another site. These sites are not under the control of Evive Biotech. Click Continue to proceed or Cancel to go back.

NEWS LIST

Evive Biotech signs an exclusive distribution agreement with Lenis Group to commercialize Ryzneuta in 8 markets in Central and Eastern Europe
Jun 12, 2025
Evive Biotech and I'rom Group Collaborate on Development of Innovative Drug Ryzneuta®
Apr 30, 2025
Evive Biotech and APOGEPHA announce the launch of Ryzneuta® (Efbemalenograstim alfa Injection) in Germany, the first oversea market launched under Ryzneuta® 's globalization plan
Nov 07, 2024

You are now leaving the Evive Biotech website. Evive offers links to other third party websites that may be of interest to our website visitors. When you click on these links you will leave the Evive’s website and will be redirected to another site. These sites are not under the control of Evive Biotech. Click Continue to proceed or Cancel to go back.

You are now leaving the Evive Biotech website. Evive offers links to other third party websites that may be of interest to our website visitors. When you click on these links you will leave the Evive’s website and will be redirected to another site. These sites are not under the control of Evive Biotech. Click Continue to proceed or Cancel to go back.